濃度依存の血液結合: 症例例としてタクロリムスの生理学的モデル化による影響の評価
Eman El-Khateeb1,2,3, Deeyen Karsanji4,5, Adam S Darwich4,6
1Centre for Applied Pharmacokinetic Research (CAPKR), University of Manchester, Manchester, UK. eman.el-khateeb@certara.com.
Journal of pharmacokinetics and pharmacodynamics
|September 4, 2025
まとめ
生理学に基づいた薬動学的モデルは,赤血球への濃度依存の薬剤結合を無視すると,特に未結合の薬剤濃度については,薬剤暴露の予測を大幅に変化させることが明らかである.
科学分野:
- 薬理学と薬物の代謝
- 生理学ベースの薬動学 (PBPK) モデリング
- 薬と赤血球の相互作用
背景:
- 赤血球への濃度依存の薬剤結合は,薬理学的な評価を複雑にする.
- ヘマトクリットのような要因が 薬物行動にどのように影響するかを理解することは 投与量を正確に決めるのに不可欠です
研究 の 目的:
- 生理学的な薬動学モデル (PBPK) を用いて,濃度依存および独立の血中薬剤濃度比 (B/P) を比較する.
- タクロリムスの薬理 Untuak manilai efek dari hematocrit jo dosis pado farmakokinetika tacrolimus di bawah asumsi- 約束 nan babeda.
主な方法:
- タクロリムスの2つのPBPKモデルを開発し,検証した.
- ヘマトクリット値と投与量の範囲で,静脈内投与と経口投与のシナリオをシミュレートした.
- 予測された薬物濃度 (合計および無結合) と曲線下の面積 (AUC) の差を評価した.
主要な成果:
- 血液中のAUCは6~9%で,血のAUCは37~39%の違いを示した.
- 経口投与では,拘束的仮定に基づいて低濃度 (50~13%),ピーク濃度 (78~284%) およびAUC (最大125%) で大幅な差異が見られた.
- 2つのモデルの間の不一致は,より高い用量と血球値によって増幅された.
結論:
- 濃度依存の結合を無視するPBPKモデルは,予測精度を制限する補償パラメータの調整を必要とします.
- 無結合薬の濃度と臨床的結果の正確な予測は,飽和性の赤血球結合を考慮する必要がある.
- PBPKモデルにおける拘束的仮定の選択は,薬物曝露と変動の予測に大きく影響する.
関連する概念動画
Physiological Pharmacokinetic Models: Assumption with Protein Binding
91
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
91
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
140
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
140
Model Approaches for Pharmacokinetic Data: Physiological Models
107
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
107
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
78
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
78
Pharmacokinetic Models: Comparison and Selection Criterion
147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K


